Abstract
BackgroundTargeting neoantigens by adoptive cell therapy (ACT) can effectively treat advanced solid tumors.1–5 However, the conventional rapid expansion protocol (REP) for T-cell expansion can stimulate bystander cells6–8 and cause differentiation...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
